LYCOS RETRIEVER 
Genetics: Genetics Program
built 624 days ago
Lexicon Genetics is a biopharmaceutical company focused on discovering and developing new ways to treat human disease. Lexicon is systematically discovering the physiological and behavioral functions of genes to identify potential points of therapeutic intervention, or drug targets. Using its proprietary gene knockout technology, Lexicon has advanced more than 60 validated small molecule and biotherapeutic targets into drug discovery programs in six therapeutic areas. Lexicon is working both independently and through strategic collaborations and alliances to accelerate the development and commercialization of its discoveries. Additional information about Lexicon is available through its corporate website, http://www.lexicon-genetics.com .
Source:
Lexicon Genetics is a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease. Lexicon is systematically discovering the physiological and behavioral functions of genes to identify potential points of therapeutic intervention, or drug targets. Lexicon makes these discoveries using its proprietary gene knockout technology to model the physiological effects that could be expected from prospective drugs addressing these targets. For targets that the company believes have high pharmaceutical value, it engages in programs for the discovery and development of small molecule, antibody and protein drugs. Lexicon has advanced knockout-validated targets into drug discovery programs in six therapeutic areas: diabetes and obesity, cardiovascular disease, psychiatric and neurological disorders, cancer, immune system disorders and ophthalmic disease. Lexicon is working both independently and through collaborations and strategic alliances to accelerate the development and commercialization of its discoveries.
Source:
Targeted Genetics Corporation develops gene-based products for preventing and treating acquired and inherited diseases. The Company has three clinical product development programs, targeting cystic fibrosis, AIDS prophylaxis and rheumatoid arthritis. The Company ... has a promising pipeline of product candidates focused on hemophilia and cancer and a broad platform of gene delivery technologies, as well as a promising body of technology for cellular therapy under development by its subsidiary company, CellExSys. For more information about the Company visit its website at www.targetedgenetics.com.
Source:
Targeted Genetics Corporation develops molecular medicines for the prevention and treatment of acquired and inherited diseases. The Company has clinical product development programs targeting inflammatory arthritis and AIDS prophylaxis. The Company ... has a promising pipeline of preclinical product development programs focused on congestive heart failure, Huntington's disease, and hyperlipidemia. For more information about Targeted Genetics, visit its website at www.targetedgenetics.com.
Source:
Genetics is an interdisciplinary graduate degree-granting program that contains a diverse cross-section of faculty with a shared interest in genetics. The graduate program is administered by the Faculty of Genetics, which, as of September 2004, consists of 89 members from 19 departments in the TAMU Colleges of Agriculture, Science. and Veterinary Medicine, as well as the TAMU System Health Science Center College of Medicine (College Station) and Albert Alkek Institute of Biosciences and Technology (Houston).
Source:
Medical Genetics at DHMC provides diagnosis, treatment, genetic testing and genetic counseling for individuals with known or suspected inherited medical problems. Medical Genetics is staffed by Board Certified Medical Geneticists, Cytogeneticists, Molecular Geneticists and Genetic Counselors. The Program is a collaboration of the Departments of Pediatrics, Ob/GYN, Pathology, Medicine and the Norris Cotton Cancer Center. Medical Genetics at DHMC is affiliated with the Department of Genetics, Dartmouth Medical School.
Source:
MORE ABOUT
Genetics Program